Earth Science Tech (ETST) Income from Continuing Operations (2011 - 2025)
Earth Science Tech (ETST) reported Income from Continuing Operations of 910368.0 for Q4 2025, up 341.05% on a YoY basis from 206411.0 in Q4 2024, and down 3.76% quarter-over-quarter from 945897.0 in Q3 2025.
Earth Science Tech (ETST) Income from Continuing Operations (2011 - 2025) Analysis & Trends
Earth Science Tech has reported Income from Continuing Operations for 14 years, with the latest figure at 910368.0 in Q4 2025.
- For the quarter ending Q4 2025, Income from Continuing Operations rose 341.05% year-over-year to 910368.0; the trailing twelve-month figure through Dec 2025 stood at 3485580.0 (up 50.87% YoY), and the FY2025 full-year result was 3253634.0, up 300.63% from the prior year.
- Income from Continuing Operations for Q4 2025 stood at 910368.0, down from 945897.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 3341399.0 in Q3 2021, with the low at 235509.0 in Q1 2023.
- Historically, Income from Continuing Operations has averaged 451066.3 across 5 years, with a median of 215927.0 in 2023.
- Annual changes were most pronounced in 2023 — Income from Continuing Operations plunged 667.61% — and 2024, when it jumped 3123.53%.
- Earth Science Tech's Income from Continuing Operations stood at 115048.0 in 2021, then surged by 185.59% to 98464.0 in 2022, then surged by 128.96% to 225443.0 in 2023, then retreated by 8.44% to 206411.0 in 2024, then surged by 341.05% to 910368.0 in 2025.
- The last three Income from Continuing Operations figures came in at 910368.0 (Q4 2025), 945897.0 (Q3 2025), and 456714.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 21.05 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -92.12 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 118.42 Mn |
| 10 | Earth Science Tech | - | - | 6.40 Mn | 910,368.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 910,368.00 |
| Sep 30, 2025 | 945,897.00 |
| Jun 30, 2025 | 456,714.00 |
| Mar 31, 2025 | 1.17 Mn |
| Dec 31, 2024 | 206,411.00 |
| Sep 30, 2024 | 798,368.00 |
| Jun 30, 2024 | 1.08 Mn |
| Mar 31, 2024 | 229,324.00 |
| Dec 31, 2023 | 225,443.00 |
| Sep 30, 2023 | 444,581.00 |
| Jun 30, 2023 | -35,596.00 |
| Mar 31, 2023 | -235,509.00 |
| Dec 31, 2022 | 98,464.00 |
| Sep 30, 2022 | -73,678.00 |
| Jun 30, 2022 | -154,682.00 |
| Mar 31, 2022 | -30,681.00 |
| Dec 31, 2021 | -115,048.00 |
| Sep 30, 2021 | 3.34 Mn |
| Jun 30, 2021 | -22,410.00 |
| Mar 31, 2021 | -216,894.00 |